1d
Condé Nast Traveler on MSNWhat You Need to Know About the Risk of Blood Clots on Long FlightsWhen someone is about to board a long flight, a list of things to worry about often runs through their head: Will I actually ...
Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and ...
UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... in combination with inhaled corticosteroids (ICS), so ...
Hospitalists work hard (not that we have to tell you that!), so celebrating March 6 as National Hospitalist Day is an ideal ...
5d
News Medical on MSNElderly populations: Global trends in the healthy aging marketA global elderly and aging population has significant impacts, not only in terms of individual health risk but in terms of ...
A US study found a significantly higher cost of care associated with cirrhosis vs with heart failure or chronic obstructive pulmonary disease.
When the sedatives and antidepressants prescribed for PTSD don't work, some veterans have found peace through psychedelics.
ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.
Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...
Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...
Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...
Americans with a chronic disease could soon have better access to affordable treatment if a bipartisan bill just passed by the U.S. House makes it through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results